FierceHealthcareFierceHealthITFierceHealthFinanceFierceEMRHospital ImpactFierceMobileHealthcare   FiercePharma

SPOTLIGHT: FDA requiring suicide tracking in drug trials

Tools
Tags
Food and Drug Administration (FDA)
medicines
decade


For more than a decade, drug makers have not been required to pay much attention to the potential psychiatric side effects generated by experimental medicines. Now, however, new FDA rules will require drug makers to look closely at whether patients become suicidal during drug trials. Drug makers will now have to include a comprehensive suicide assessment scale into every trial. Article

Bookmark and Share
Get Your FREE FierceHealthcare Email Newsletter:
Be the first to comment

Comments

Post new comment

The content of this field is kept private and will not be shown publicly.

More information about formatting options

To combat spam, please enter the code in the image.